UW biotech spinout DMD Therapeutics raises $400k to pursue treatment for rare form of muscular dystrophy by Clare McGrane on February 27, 2017February 27, 2017 at 10:19 am DMD Therapeutics, a biotech startup that was spun out of the University of Washington by biotech entrepreneur Ron Berenson last year, is emerging from stealth mode. The startup announced that it raised… Read More